MediPharm Labs (OTC: MEDIF)
MediPharm Labs Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
MediPharm Labs Company Info
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
News & Analysis
10 Pot Stocks Expected to Grow Sales by 60% (or More) in 2021
Despite a recent rough patch, the marijuana industry should deliver exciting sales growth next year.
MediPharm Sinks by Over 14% on Q1 Results
A steep fall in demand and the economic ravages of the coronavirus badly affected the company's business.
3 Pot Stocks to Stay Miles Away From
There are good marijuana stocks out there, but these Canadian cannabis companies have serious red flags.
MediPharm Australia Subsidiary Signs Its First European Private-Label Supply Deal
The company links up with U.K.-based pharmaceutical supply-chain specialist Therismos.
The 9 Best Marijuana Stocks in April
Finally, pot stock investors have something to cheer about.
10 Brand-New Stocks I Bought During the Stock Market Crash
Bear markets have always represented an excellent time for investors to go shopping.
4 Canadian Pot Stocks Expected to Be Profitable in 2021
Canadian marijuana stocks have been hammered, but these select cannabis companies are on track to deliver the green next year.
5 Pot Stocks That Can Survive the Coronavirus Crash
These marijuana stocks have the tools to outlast the COVID-19 pandemic.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.